• Gilead and Galapagos announce positive topline results of Phase 2B/3 trial of Filgotinib

    Thursday May 21st 2020

  • Mithra and Searchlight Pharma announce filing of new drug submission for Estelle® in Canada

    Wednesday May 20th 2020

  • ProDigest and CosmosID announce a winner for the ‘Gut Microbiome Therapeutic Innovation’ challenge

    Tuesday May 19th 2020

  • Bone Therapeutics treats first patients in pivotal JTA-004 phase III knee osteoarthritis study

    Monday May 18th 2020

  • Enzymicals and Syngulon sign a non-exclusive license agreement

    Friday May 15th 2020

  • VIB field test with maize variety to check drought tolerance in practice

    Friday May 15th 2020

  • Progressing clinical development of next generation therapies for Diabetic eye disease – beyond anti-VEGF

    Friday May 8th 2020

  • Galapagos: On track for clinical read-outs

    Friday May 8th 2020

  • Your news here?

  • BioVox: the global network for Belgian life sciences turns five and launches a new website!

    Friday May 8th 2020

  • Obesity is linked to gut microbiota disturbance, but not among statin-treated individuals

    Thursday May 7th 2020

  • VIB’s efforts in COVID-19 testing

    Thursday May 7th 2020


Strategic Partners